TDOC
Teladoc Health, Inc. · Healthcare · Medical - Healthcare Information Services
Momentum inputs (comparable managers):
holder breadth -7.7% ·
share flow -19.4% ·
net new positions -8.3%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 88.23K | $488,810 | n/a | −2 |
| Q2 2026 | 111 | +6 | 112.96M | $926.27M | +10 | −5 |
| Q1 2026 | 109 | +2 | 103.34M | $549.43M | +5 | −3 |
| Q4 2025 | 106 | -1 | 112.74M | $760.88M | n/a | −1 |
| Q3 2025 | 19 | +1 | 71.06M | $549.33M | +2 | −2 |
| Q2 2025 | 16 | -1 | 66.90M | $582.70M | n/a | −1 |
| Q1 2025 | 14 | +1 | 30.12M | $239.71M | +1 | n/a |
| Q4 2024 | 13 | 0 | 34.32M | $311.99M | +2 | −2 |
| Q3 2024 | 12 | -1 | 22.43M | $205.74M | +1 | −2 |
| Q2 2024 | 13 | n/a | 27.83M | $272.20M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 8.37M | +57.8% | $76.80M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 4.91M | -10.2% | $45.09M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 3.93M | +1.5% | $36.04M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 4 | Wellington Management ✦ | 3.20M | +30.4% | $29.36M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 5 | Citadel Advisors ✦ | 612.81K | +496.1% | $5.63M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | AQR Capital Management ✦ | 458.90K | -32.1% | $4.02M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 7 | Marshall Wace ✦ | 394.13K | New | $3.62M | 0.0% | New | 1 | SEC ↗ ×2 |
| 8 | Millennium Management ✦ | 275.52K | -32.8% | $2.53M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 9 | T. Rowe Price ✦ | 122.73K | +22.6% | $1.13M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Bridgewater Associates ✦ | 112.81K | -52.3% | $1.04M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 54.07K | -71.6% | $496,372 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 12 | ARK Investment Management ✦ | 0 | -100.0% | $0 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $3.62M | 0.0% |
Exited
| Norges Bank | $14.93M | was 0.0% |
| GAMCO Investors | $141,272 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 250.00K shares, $1,362 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 655 sh · $3,703
Officer, Director · 17.80K sh · $108,682
Officer · 7.36K sh · $46,356
Officer, Director · 18.33K sh · $115,478
Officer · 274 sh · $1,726
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology